ebook img

Using the ARCS Framework to explore motivational factors that may influence rates of offering PDF

222 Pages·2016·3.52 MB·English
Save to my drive
Quick download
Download
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Using the ARCS Framework to explore motivational factors that may influence rates of offering

Using the ARCS Framework to explore motivational factors that may influence rates of offering adults vaccinations in primary care A DISSERTATION SUBMITTED TO THE FACULTY OF UNIVERSITY OF MINNESOTA BY Wendy Michelle Scheckel IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY Laël Cranmer Gatewood, MS, PhD, FACMI and Barbara Yawn, MD, MSc, FAAFP May, 2016 © Wendy Michelle Scheckel, 2016 Acknowledgements I would like to acknowledge my committee members: Don Connelly, MD, PhD, FACMI, Lael Gatewood, MS, PhD, FACMI, Sripriya Rajamani, MBBS, PhD, MPH, Stuart Speedie, PhD, FACMI, and Barbara Yawn, MD, MSc, FAAFP. In particular, I want to acknowledge Dr. Speedie for being the chair of my committee. I want to especially thank my co-advisers: Dr. Gatewood and Dr. Yawn. Their mentoring and assistance throughout the entire process was greatly appreciated. I would like to sincerely thank Dr. Peter Wollan who acted as my biostatistician consultant. Dr. Wollan has an amazing ability to explain complex statistical methods in an easy-to-understand format that helped me tremendously. His knowledge, expertise, and experience were invaluable and appreciated beyond what words can express. His technical support was only surpassed by his emotional support and encouragement. I would not have made it without his help and friendship. I would also like to acknowledge the leadership, staff, and patients at the healthcare organization where the study took place. Without the support of the leadership and participation from the staff and patients, this research would not have been possible. I would like to thank the many colleagues and staff of mine for their continued support and encouragement throughout this process. Their concern and kind words were greatly appreciated. Lastly, I would like to acknowledge and thank all of my family and friends for their prayers and support. iii Dedication First of all, this dissertation is dedicated to my Lord and Savior, Jesus Christ. “I can do all things through him who strengthens me” (Philippians 4:13 ). He is my rock and strong tower who is merciful, faithful, and true. “Your steadfast love, O LORD, extends to the heavens, your faithfulness to the clouds” (Psalm 36:5). Secondly, I dedicate this dissertation to my husband, Matt and son, Christian. Their continued support and love carried me throughout the entire process. They were patient, understanding, and encouraging every step of the way. They made many sacrifices willingly and without complaint. They deserve my utmost respect and gratitude for all of their help throughout this entire journey. I love them more than words could ever express and I am eternally blessed to have them in my lives. Finally, I would like to dedicate this dissertation to my Mom, Nancy. She was my biggest fan. Cheering me along the entire path, she always had words of encouragement and reassurance. Her support was invaluable and appreciated more than I could ever let her know. iv Abstract This research study explored motivational factors of clinical staff in 12 primary care sites at one integrated, regional healthcare organization that may help explain variation in rates of offering pneumococcal, influenza, and pertussis vaccinations to adults age 18 and older using Keller’s Attention, Relevance, Confidence, and Satisfaction (ARCS) framework. Analysis of the organization’s comprehensive EHR and its use of a statewide registry was used to calculate eligible encounters and rates of vaccine administration success to adult patients. The Keller Course Interest Survey originally designed to assess motivation in students was modified to a clinical care construct and administered to all primary care staff with patient contact. Separate analyses for influenza, pertussis and pneumococcal vaccines approximated state and US levels, with large variability between sites. Motivational scores differed significantly between sites and between clinicians, rooming staff and receptionists at each site. Rooming staff interviews revealed variability related to adherence to organizational policy and protocol including a lack of documentation of patient refusals to receive vaccinations and clinicians functioning autonomously and independently outside the documented guidelines. Several patient demographics, site, and the motivational domains of attention and satisfaction were all found to be statistically significant in a stepwise multiple logistic regression model of factors contributing to the success of offering influenza, pertussis, and pneumococcal vaccinations to adults. Rates of offering vaccines to adults can be improved using motivational design methods to improve and support the motivational domains of attention and satisfaction by implementing targeted educational strategies and key electronic health record design changes. The goal of these interventions would be to more easily identify eligible patients, better understand vaccination guidelines, offer clinical decision support, and provide valuable feedback in the success of offering vaccinations to adults. v Table of Contents List of Tables ..................................................................................................................... ix List of Figures ................................................................................................................... xii CHAPTER 1 – INTRODUCTION ..................................................................................... 1 1.1 – STATEMENT OF THE PROBLEM ..................................................................... 2 1.2 – BACKGROUND ................................................................................................... 3 1.3 – RATIONALE OF THE STUDY AND ITS METHODS ...................................... 5 1.4 – STATEMENT OF SPECIFIC AIMS..................................................................... 5 1.5 – LAYOUT OF THESIS .......................................................................................... 6 CHAPTER 2 – LITERATURE REVIEW .......................................................................... 8 2.1 – HEALTH INFORMATION TECHNOLOGY ...................................................... 8 2.2 – PREVENTIVE SERVICES ................................................................................. 10 2.3 – TRANSLATIONAL RESEARCH ...................................................................... 12 2.4 – GUIDELINES IN EVIDENCE-BASED PRACTICES....................................... 14 2.5 – CLINICIAN ADHERENCE TO GUIDELINES ................................................. 16 2.6 – THEORETICAL FRAMEWORKS OF BEHAVIOR ......................................... 18 2.7 – THE ARCS MODEL OVERVIEW ..................................................................... 21 2.7.1 – ARCS – Attention ......................................................................................... 22 2.7.2 – ARCS – Relevance ....................................................................................... 23 2.7.3 – ARCS – Confidence ...................................................................................... 23 2.7.4 – ARCS – Satisfaction ..................................................................................... 24 2.7.5 – ARCS Instrumentation – Course Interest Survey (CIS) ............................... 24 2.8 – SURVEY METHODS ......................................................................................... 26 2.9 – INTERVIEW METHODS ................................................................................... 28 CHAPTER 3 – RESEARCH METHODS ........................................................................ 32 3.1 – RESEARCH DESIGN ......................................................................................... 32 3.1.1 – Setting ........................................................................................................... 33 3.1.2 – Participants .................................................................................................... 34 3.1.3 – Institutional Review Board and State Law ................................................... 35 3.2 –COMPARING RATES USING THE EHR METHODS...................................... 35 3.2.1 – Data Collection – Query Development ......................................................... 35 3.2.2 – Rate Calculation ............................................................................................ 37 3.2.3 – Data Analysis and Validation Methods ........................................................ 42 3.3 – MOTIVATION SURVEY METHODS ............................................................... 44 3.3.1 – Motivational Model ...................................................................................... 45 3.3.2 – Motivational Survey Tool ............................................................................. 45 3.3.3 – Motivational Survey Distribution ................................................................. 48 3.3.4 – Motivational Survey Pilot ............................................................................. 51 3.3.5 – Motivational Survey Tracking ...................................................................... 52 3.3.6 – Motivational Survey Scoring Methods ......................................................... 53 3.4 – STAFF INTERVIEW METHODS ...................................................................... 54 3.4.1 – Interview Participants ................................................................................... 54 3.4.2 – Conducting the Interview .............................................................................. 55 vi 3.4.3 – Documenting the Interview........................................................................... 57 3.4.4 – Systematic Interview Analysis ...................................................................... 58 3.4.5 – Interview Pilot ............................................................................................... 59 3.5 – MODEL DEVELOPMENT METHODS ............................................................ 60 CHAPTER 4 – RESULTS ................................................................................................ 62 4.1 – SUBJECT/SITE CHARACTERISTICS .............................................................. 62 4.1.1 – Patient Encounters ........................................................................................ 62 4.1.2 – Clinic Sites – Size and Geography................................................................ 68 4.1.3 – Clinic Sites – Patient Demographic Characteristics ..................................... 70 4.1.4 – Clinic Sites – Staff ........................................................................................ 74 4.2 – FINDINGS FOR AIM 1: COMPARING RATES USING THE EHR................ 76 4.2.1 – Comparing Rates of Offering Influenza Vaccination ................................... 76 4.2.2 – Comparing Rates of Offering Pertussis Vaccination .................................... 84 4.2.3 – Comparing Rates of Offering Pneumococcal Vaccination ........................... 91 4.3 –MOTIVATION SURVEY FINDINGS ................................................................ 95 4.3.1 – Survey Adaptation ........................................................................................ 95 4.3.2 – Pilot Study to Test Clinical Care Construct Survey...................................... 99 4.3.3 – Response Rates ........................................................................................... 102 4.3.4 – Missing Data ............................................................................................... 103 4.3.5 – ARCS Scores .............................................................................................. 105 4.4 – STAFF INTERVIEW FINDINGS ..................................................................... 110 4.4.1 – Organizational Policy.................................................................................. 110 4.4.2 – Response ..................................................................................................... 111 4.4.3 – Summary Analysis ...................................................................................... 114 4.5 – FINDINGS FOR AIM 4: MOTIVATION AS A PREDICTOR FOR VACCINATION SUCCESS ...................................................................................... 116 4.5.1 – Influenza ..................................................................................................... 116 4.5.2 – Pertussis ...................................................................................................... 123 4.5.3 – Pneumococcal ............................................................................................. 128 4.6 – SUMMARY ....................................................................................................... 133 CHAPTER 5 – DISCUSSION ........................................................................................ 134 5.1 – SUBJECT/SITE CHARACTERISTICS ............................................................ 134 5.1.1 – Patient Encounters ...................................................................................... 134 5.1.2 – Clinic Sites .................................................................................................. 135 5.2 – AIM 1: COMPARING RATES USING THE EHR .......................................... 137 5.2.1 – Comparing Rates of Offering Influenza Vaccination ................................. 138 5.2.2 – Comparing Rates of Offering Pertussis Vaccination .................................. 140 5.2.3 – Comparing Rates of Offering Pneumococcal Vaccination ......................... 141 5.3 – AIM 2: MOTIVATION SURVEY .................................................................... 144 5.3.1 – Survey Adaptation ...................................................................................... 144 5.3.2 – Response Rates ........................................................................................... 146 5.3.3 – Missing Data ............................................................................................... 146 5.3.4 – ARCS Scores .............................................................................................. 147 5.4 – AIM 3: INTERVIEWS ...................................................................................... 149 vii 5.5 – AIM 4: MOTIVATION AS A PREDICTOR FOR VACCINATION SUCCESS ..................................................................................................................................... 152 5.5.1 – Influenza ..................................................................................................... 152 5.5.2 – Pertussis ...................................................................................................... 155 5.5.3 – Pneumococcal ............................................................................................. 156 5.4.4 – Aims 1-4: Integration of Results across Vaccinations ................................ 158 5.6 – RECOMMENDATIONS ................................................................................... 161 5.7 – COMPARISON WITH WORK OF OTHERS .................................................. 163 5.8 – STRENGTHS .................................................................................................... 166 5.9 – LIMITATIONS AND ASSUMPTIONS ........................................................... 168 5.10 – CONTRIBUTIONS ......................................................................................... 171 5.11 – SUGGESTIONS FOR FUTURE RESEARCH ............................................... 174 CHAPTER 6 – CONCLUSIONS ................................................................................... 177 Bibliography ....................................................................................................................181 Appendix ..........................................................................................................................186 viii List of Tables Table 1. Course Interest Survey Internal Consistency Estimates (4)................................ 26 Table 2. At-Risk Conditions for the Pneumococcal Vaccination and the Corresponding ICD-9 Diagnosis Codes to Determine Eligibility for Vaccination (5) ............................. 40 Table 3. Statements from the Original Course Interest Survey Developed by Keller (4) 47 Table 4. Number of Encounters with the Number of Eligible Vaccinations .................... 63 Table 5. Number of Encounters and Individual Patients by Sex ...................................... 64 Table 6. Original Race Categories and Number of Corresponding Encounters; Grouping of Original Race into Broader Race Categories and Number of Corresponding Encounters ........................................................................................................................................... 65 Table 7. Number of Encounters and Individual Patients by Ethnicity ............................. 66 Table 8. Number of Encounters and Individual Patients by Language ............................ 66 Table 9. Number of Encounters and Individual Patients by Insurance Status .................. 67 Table 10. Site Groupings by Geographical Location and Size and Total Number of Encounters......................................................................................................................... 69 Table 11. Number of Staff by Job Category by Site ......................................................... 75 Table 12. Percent of Offering Influenza Vaccination Success by Site ............................. 77 Table 13. Univariate Analysis of Demographic Factors to Determine Contribution to the Success of Offering Influenza Vaccination ...................................................................... 78 Table 14. Patient Demographics Analyzed to Determine Contribution to the Success of Offering Influenza Vaccination Using Multiple Analysis ................................................ 78 Table 15. Patient Demographics Analyzed to Determine Contribution to the Success of Offering Influenza Vaccination Using Multiple Analysis Removing Insignificant Factors (Ethnicity) ......................................................................................................................... 79 Table 16. Final Multiple Logistic Regression Model of Offering Influenza Vaccination Success .............................................................................................................................. 83 Table 17. Percent of Offering Pertussis Vaccination Success by Site .............................. 84 Table 18. Patient Demographics Analyzed to Determine Contribution to the Success of Offering Pertussis Vaccination Using Univariate Analysis .............................................. 85 Table 19. Patient Demographics Analyzed to Determine Contribution to the Success of Offering Pertussis Vaccination Using Multiple Analysis ................................................. 85 Table 20. Patient Demographics Analyzed to Determine Contribution to the Success of Offering Pertussis Vaccination Using Multiple Analysis Removing Insignificant Factors (Ethnicity and Language) .................................................................................................. 86 Table 21. Final Multiple Logistic Regression Model of Offering Pertussis Vaccination Success .............................................................................................................................. 90 Table 22. Percent of Offering Pneumococcal Vaccination Success by Site ..................... 91 Table 23. Patient Demographics Analyzed to Determine Contribution to the Success of Offering Pneumococcal Vaccination Using Univariate Analysis ..................................... 92 Table 24. Patient Demographics Analyzed to Determine Contribution to the Success of Offering Pneumococcal Vaccination Using Multiple Analysis ........................................ 92 ix Table 25. Final Multiple Logistic Regression Model of Offering Pneumococcal Vaccination Success.......................................................................................................... 94 Table 26. Clinical Care Construct Survey (Questions 1-16) ............................................ 97 Table 27. Adjustments Made to the CCCS Based on Comments During the Pilot Phase ......................................................................................................................................... 101 Table 28. Survey Rate of Return by Site and Job Category ........................................... 102 Table 29. Unanswered Questions by ARCS Domain and Job Category per Returned Survey ............................................................................................................................. 104 Table 30. Univariate Analysis of ARCS Domain Scores and Successful Offering of Influenza Vaccination ..................................................................................................... 117 Table 31. Domain Score and Job Category as Contributing Factor to the Success of Offering Influenza Vaccination using Univariate Analysis ............................................ 118 Table 32. Multiple Logistic Regression of ARCS Domain Scores and Successful Offering of Influenza Vaccination for All Staff ............................................................................ 119 Table 33. Logistic Regression of ARCS Domain Scores and Successful Offering of Influenza Vaccination for Each Job Category ................................................................ 120 Table 34. Logistic Regression of ARCS Domain Scores and Successful Offering of Influenza Vaccination Adjusting for Significant Patient Demographic Characteristics 121 Table 35. Logistic Regression of ARCS Domain Scores and Successful Offering of Influenza Vaccination Adjusting for Significant Patient Demographic Characteristics 122 Table 36. Univariate Analysis of ARCS Domain Scores and Successful Offering of Pertussis Vaccination ...................................................................................................... 123 Table 37. Univariate Analysis of ARCS Domain Scores and Successful Offering of Pertussis Vaccination ...................................................................................................... 124 Table 38. Multiple Logistic Regression of ARCS Domain Scores and Successful Offering of Pertussis Vaccination for All Staff ............................................................................. 125 Table 39. Logistic Regression of ARCS Domain Scores and Successful Offering of Pertussis Vaccination for Each Job Category ................................................................. 126 Table 40. Logistic Regression of ARCS Domain Scores and Successful Offering of Pertussis Vaccination Adjusting for Significant Patient Demographic Characteristics . 127 Table 41. Univariate Analysis of ARCS Domain Scores and Successful Offering of Pneumococcal Vaccination ............................................................................................. 128 Table 42. Univariate Analysis of ARCS Domain Scores and Successful Offering of Pertussis Vaccination ...................................................................................................... 129 Table 43. Multiple Logistic Regression of ARCS Domain Scores and Successful Offering of Pneumococcal Vaccination for All Staff .................................................................... 130 Table 44. Logistic Regression of ARCS Domain Scores and Successful Offering of Pneumococcal Vaccination for Each Job Category ........................................................ 131 Table 45. Logistic Regression of ARCS Domain Scores and Successful Offering of Pneumococcal Vaccination Adjusting for Significant Patient Demographic Characteristics ................................................................................................................. 132 Table 46. Sites by the Number of Encounters with the Encounter to Clinician Ratio ... 136 Table 47. Ratio of Rooming Staff and Receptionists to Clinician by Site ..................... 137 Table 48. Average Domain Score (All Job Categories) Ranking by Site ....................... 148 x

Description:
2.7.5 – ARCS Instrumentation – Course Interest Survey (CIS) . 24 as suture removal, casting,. EEGs, or EKGs were excluded.
See more

The list of books you might like

Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.